Skip to main content

IOVANCE BIOTHERAPEUTICS, INC.

For the period ended Sep 30, 2026. Filed Nov 5, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Nov 5, 2026

IOVA$8.17+1.6%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Item 6. Exhibits

EXHIBIT INDEX

ExhibitDescription
3.1Certificate of Incorporation, as amended, of Registrant (incorporated herein by reference to Exhibit 3.1 to Registrant’s Form S-3 filed with the Commission on June 18, 2026).
3.2Fourth Amended and Restated Bylaws of Iovance Biotherapeutics, Inc. (incorporated herein by reference to Exhibit 3.1 to Registrant’s Current Report on Form 8-K filed with the Commission on March 29, 2024).
10.1++#*Executive Employment Agreement, effective as of September 30, 2026, by and between Noah Berkowitz and Iovance Biotherapeutics, Inc.
10.2++#Iovance Biotherapeutics, Inc. Amended and Restated 2021 Inducement Plan, as amended
31.1++Rule 13a-14(a)/15d-14(a) Certification of Chief Executive Officer.
31.2++Rule 13a-14(a)/15d-14(a) Certification of Principal Financial Officer.
32.1++Section 1350 Certification of Chief Executive Officer (furnished herewith).
32.2++Section 1350 Certification of Principal Financial Officer (furnished herewith).
101.INS++Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document).
101.SCH++Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents.
104Cover Page Interactive Data File (the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document).

++ Filed herewith (unless otherwise noted as being furnished herewith).

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.